Spironolactone is superior to hydrochlorothiazide for blood pressure control and arterial stiffness improvement
| Autor: | Siping Dai, Huocheng Liao, Chun Xiao, Lin Liu, Yan Liu |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Blood pressure control
medicine.medical_specialty business.industry Treatment outcome General Medicine 030204 cardiovascular system & hematology medicine.disease law.invention 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Hydrochlorothiazide Blood pressure chemistry Randomized controlled trial law Internal medicine Spironolactone medicine Arterial stiffness Cardiology 030212 general & internal medicine Prospective cohort study business medicine.drug |
| Zdroj: | Medicine. 97:e0500 |
| ISSN: | 0025-7974 |
| Popis: | The present study is to investigate whether spironolactone is better than hydrochlorothiazide (HCTZ) for blood pressure (BP) control and arterial stiffness improvement. Five-hundred-sixty-six uncontrolled hypertensive patients with 2 different classes of antihypertensive medications treatmen |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|